Michele Potashman

6.6k total citations
39 papers, 666 citations indexed

About

Michele Potashman is a scholar working on Neurology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Michele Potashman has authored 39 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 14 papers in Psychiatry and Mental health and 11 papers in Molecular Biology. Recurrent topics in Michele Potashman's work include Dementia and Cognitive Impairment Research (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (10 papers). Michele Potashman is often cited by papers focused on Dementia and Cognitive Impairment Research (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (10 papers). Michele Potashman collaborates with scholars based in United States, United Kingdom and Netherlands. Michele Potashman's co-authors include Mark E. Duggan, Fariba Mirzaei, Nancy N. Maserejian, M. Arfan Ikram, Jeffrey L. Cummings, S. Knox, Sarah Cohen, John Harrison, Pierre Krolak‐Salmon and Ivana Rubino and has published in prestigious journals such as Blood, Neurology and Journal of Medicinal Chemistry.

In The Last Decade

Michele Potashman

34 papers receiving 655 citations

Peers

Michele Potashman
Yeh‐Fong Chen United States
Luc Truyen United States
Bangning Yu United States
Ch Davis United States
Venkatesh Pilla Reddy United States
Paul Leber United States
Eric Yang United States
Yeh‐Fong Chen United States
Michele Potashman
Citations per year, relative to Michele Potashman Michele Potashman (= 1×) peers Yeh‐Fong Chen

Countries citing papers authored by Michele Potashman

Since Specialization
Citations

This map shows the geographic impact of Michele Potashman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Potashman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Potashman more than expected).

Fields of papers citing papers by Michele Potashman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Potashman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Potashman. The network helps show where Michele Potashman may publish in the future.

Co-authorship network of co-authors of Michele Potashman

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Potashman. A scholar is included among the top collaborators of Michele Potashman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Potashman. Michele Potashman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Potashman, Michele, Evan Popoff, Lauren Powell, et al.. (2025). Measurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia. Neurology and Therapy. 14(2). 527–545.
2.
Potashman, Michele, K. Rüdell, Linda Abetz‐Webb, et al.. (2025). Content Validity of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia. Neurology and Therapy. 14(2). 547–563. 1 indexed citations
3.
Potashman, Michele, K. Rüdell, Linda Abetz‐Webb, et al.. (2025). Understanding lived experiences with KCNQ2 developmental and epileptic encephalopathy. Epilepsy & Behavior. 172. 110670–110670. 1 indexed citations
4.
LʼItalien, G., Lauren Powell, Michele Potashman, et al.. (2025). Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease. Neurology and Therapy. 14(4). 1609–1625.
5.
Potashman, Michele, K. Rüdell, Linda Abetz‐Webb, et al.. (2025). Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia. The Cerebellum. 24(5). 146–146.
6.
Potashman, Michele, K. Rüdell, Ivanna M. Pavisic, et al.. (2024). Content Validity of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) Instrument in Spinocerebellar Ataxia. The Cerebellum. 23(5). 2012–2027. 8 indexed citations
8.
Potashman, Michele, et al.. (2024). The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study. Parkinsonism & Related Disorders. 130. 107194–107194. 2 indexed citations
9.
L’Italien, Gilbert, Evangelos K. Oikonomou, Rohan Khera, et al.. (2024). Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis. Neurology and Therapy. 13(4). 1287–1301. 6 indexed citations
10.
Potashman, Michele, Evan Popoff, Lauren Powell, et al.. (2024). Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia. The Cerebellum. 23(5). 2095–2108. 5 indexed citations
13.
Dauphinot, Virginie, et al.. (2022). Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study. Alzheimer s Research & Therapy. 14(1). 34–34. 22 indexed citations
14.
Potashman, Michele, Marric Buessing, Jeffrey L. Cummings, et al.. (2021). Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data. Neurology and Therapy. 10(2). 941–953. 23 indexed citations
15.
Potashman, Michele, et al.. (2020). PND59 Estimating the Prevalence of Aβ-Confirmed Alzheimer's Disease Using a Funnel-Based Approach. Value in Health. 23. S633–S634. 3 indexed citations
16.
Landeiro, Filipa, Katie Walsh, Isaac Ghinai, et al.. (2018). Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol. BMJ Open. 8(3). e019082–e019082. 15 indexed citations
17.
Landeiro, Filipa, Isaac Ghinai, Katie Walsh, et al.. (2018). Resource utilisation and costs in predementia and dementia: a systematic review protocol. BMJ Open. 8(1). e019060–e019060. 10 indexed citations
19.
Liu, Longbin, Matthew R. Lee, Joseph L. Kim, et al.. (2016). Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling. Bioorganic & Medicinal Chemistry. 24(10). 2215–2234. 13 indexed citations
20.
Kruse, Gregory, et al.. (2014). Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphoma. Journal of Medical Economics. 17(7). 446–458. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026